Anticancer drugs: studies on experimental liver infusion and additional systemic detoxification.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000633:toxicity; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000633:toxicity; D005260:Female; D007261:Infusions, Intra-Arterial; D007262:Infusions, Intravenous; D008114:Liver Neoplasms, Experimental / Q000188:drug therapy*; D051381:Rats; D012521:Sarcosine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D013859:Thiocarbamates; D014230:Triazoles / Q000008:administration & dosage / Q000633:toxicity
D000970:Antineoplastic Agents; D013859:Thiocarbamates; D014230:Triazoles; C041113:anaxirone; C055171:sarcosine dithiocarbamate; C048341:mafosfamide; D003520:Cyclophosphamide; D012521:Sarcosine